UTAH MEDICAL PRODUCTS INC
For the period ended Apr 9, 2024. Filed Apr 10, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 9, 2024 · Filed Apr 10, 2024
Contents
Cover page
Show cover page
DEF 14A 1 utmd_def14a.htm UTAH MEDICAL FORM DEF 14A
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A****INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
| Filed by the Registrant | ☒ |
|---|
| Filed by a Party other than the Registrant | ☐ |
|---|
Check the appropriate box:
☐ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒ Definitive Proxy Statement
☐ Definitive Additional Materials
☐ Solicitation Material Under Rule 14a-12
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.